| Mr Kyle David Bridgman, LMFT | |
|
5540 N Academy Blvd Ste 210, Colorado Springs, CO 80918-3696 | |
| (719) 354-7841 | |
| Not Available |
| Full Name | Mr Kyle David Bridgman |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 5540 N Academy Blvd Ste 210, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477040905 | NPI | - | NPPES |
| 9000183743 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MFT.0001770 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kyle David Bridgman, LMFT 4360 Montebello Dr Ste 400, Colorado Springs, CO 80918-7224 Ph: (719) 246-5693 | Mr Kyle David Bridgman, LMFT 5540 N Academy Blvd Ste 210, Colorado Springs, CO 80918-3696 Ph: (719) 354-7841 |
News Archive
Boston Children's Hospital researchers have uncovered a new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex.
Similar to the dozens of Sherpas that guide hikers up treacherous Himalayan mountains to reach a summit, the nervous system relies on elaborate timing and location of guidance cues for neuronal axons-threadlike projections-to successfully reach their destinations in the body.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3, a mimetic of nerve growth factor (NGF), in a Phase II clinical trial in patients with moderate to severe dry eye disease. MIM-D3 is a small cyclic peptidomimetic of NGF, a naturally occurring protein in the eye that is responsible for the maintenance of corneal nerves and epithelium, mucin and tear production.
› Verified 8 days ago
Danielle L Demaria, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1322 N Academy Blvd, Ste. 202, Colorado Springs, CO 80909 Phone: 719-428-8939 Fax: 719-218-9001 | |
Sherri R Peach, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 411 Lakewood Cir, Ste. 110h, Colorado Springs, CO 80910 Phone: 719-597-6457 | |
Sandi L Forsythe, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 7750 N Union Blvd Ste 202, Colorado Springs, CO 80920 Phone: 719-357-8957 | |
James L Bixler, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3110 Boychuck Ave, Colorado Springs, CO 80910 Phone: 719-210-9744 Fax: 888-619-0027 | |
Nicole Bieri, MFTC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3011 Grandview St, Colorado Springs, CO 80907 Phone: 719-649-7871 | |
Mrs. Linda Meyer, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 25 N Wahsatch Ave, Suite 204, Colorado Springs, CO 80903 Phone: 719-636-2636 | |
Mrs. Lisa M Runzo, MA, LPC, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5360 N Academy Blvd, Suite 130, Colorado Springs, CO 80918 Phone: 719-227-7477 Fax: 719-227-7474 |